BJMO - volume 18, issue 1, february 2024
L. van Zuylen MD, PhD, J. van Esch MD, PhD, S. Kobes , I. van Voorthuizen , W. van der Geugten MSc, M. Slager MSc, L. de Jong MSc, L. Tulner MD, A. Rothengatter-Ophof MD, T. Efthymiou MD, M. Tenk MD, M.S. Vos MD, PhD, I. Rietkerk MSc, I. van Trigt MSc, E. Lemmens-Sauter , A. de Graeff MD, PhD
The guideline ‘Care in the dying phase’ of 2010 has been revised by a committee consisting of members mandated by several scientific, professional and patient organisations. For every module, the literature search (up to 2014) of the guideline ‘Care of dying adults in the last days of life’ from the National Institute for Health and Care Excellence (NICE) has been used. Based on a bottleneck analysis, several scientific questions were formulated with regard to marking the dying phase, the use of opioids for dyspnoea or pain, prevention and treatment of death rattle, and artificial hydration. Other parts of the guidelines were revised consensus-based. In this paper, a summary of the most important recommendations of the guideline is given.
Top
